Remove Clinical Development Remove In-Vivo Remove Manufacturing Remove Reagent
article thumbnail

Fortis Life Sciences leads the way in custom antibody discovery

Drug Discovery World

In the ever-evolving landscape of therapeutic development, the role of antibodies has become increasingly apparent. Fortis Life Sciences offers custom antibody discovery and manufacturing services for antibodies and single-domain antibodies, supporting the drug discovery market. This article is sponsored by Fortis Life Sciences.

article thumbnail

Reflecting on PEGS Europe 2023 

Drug Discovery World

GSK has developed high-throughput mammalian and E. coli expression systems and is using high-throughput expression pipelines to screen constructs for optimal expression to generate protein and cellular reagents. DDW’s Megan Thomas attended PEGS Europe 2023 in Lisbon, Portugal, from Tuesday 14 November to Thursday 16 November 2023.

article thumbnail

BioSpace Global Roundup, Oct. 15

The Pharma Data

The AOP Orphan Group manufactures 80% of its drugs in Europe and has more than 20 subsidiaries and representative offices across the whole of Europe as well as in the United Arab Emirates and Israel. Priothera expects to generate further randomized clinical data in high risk AML patients with this Series A funding round.